TransMedics Group, Inc. (TMDX)
TransMedics Group Market Cap : 2.565B for June 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 158.94B |
| DexCom, Inc. | 30.17B |
| Integer Holdings Corp. | 3.193B |
| Globus Medical, Inc. | 11.19B |
| GlucoTrack, Inc. | 1.264M |
Market Cap Related Metrics
| PE Ratio | 17.04 |
| PS Ratio | 4.624 |
| PEG Ratio | 0.0773 |
| Price to Book Value | 5.192 |
| Price to Free Cash Flow | 19.43 |
| Price | 74.24 |
| Earnings Yield | 5.87% |
| PEGY Ratio | 0.0773 |
| Operating PE Ratio | 31.14 |
| Normalized PE Ratio | 17.04 |